About the Authors

Alan Engelman

alan_engelman@dfci.harvard.edu (AE); p.cherepanov@imperial.ac.uk (PC)

Affiliation Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Division of AIDS, Harvard Medical School, Boston, Massachusetts, United States of America

Peter Cherepanov

alan_engelman@dfci.harvard.edu (AE); p.cherepanov@imperial.ac.uk (PC)

Affiliation Division of Medicine, Imperial College London, St. Mary's Campus, London, United Kingdom

Competing Interests

The authors have declared that no competing interests exist.